Y-J591 May Be Effective for Hormone-Refractory Prostate Cancer

[Guest guest]

Y-J591 May Be Effective for Hormone-Refractory Prostate Cancer

According to a recent article published in The Journal of Clinical Oncology, a compound referred to as Y-J591 may provide a treatment option for patients with hormone-refractory prostate cancer. Y-J591 is currently in the early stages of clinical trials.

http://patient.cancerconsultants.com/news.aspx?id=31268

There are 21 trials for men with Hormone-Refractory Prostate Cancer on ClinicalTrials.gov. If you are interested you can go there and do a search to see what is available.

For an additional resource on clinical trials go to center watch. http://www.centerwatch.com/ They list international trials